Birdwatch Note
2024-04-11 11:31:42 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Rak szyjki macicy nie jest nieszkodliwy, 5-letnia przeżywalność w Polsce wynosi tylko 48,3% Zespół Guillaina-Barrégo to bardzo rzadka choroba autoimmunologiczna powodująca paraliż, do tej pory nie znaleziono związku pomiędzy GBS a szczepionkami HPV https://onkologia.org.pl/pl/nowotwor-szyjki-macicy-czym-jest https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html
Written by 8BF6BDA9E97D465DA9C0474CF4F62C4585FC49E1A63BA8CF6AF6C5B175B0BB3E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1778309538539532608
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1778385431127523599
- noteId - 1778385431127523599
- participantId -
- noteAuthorParticipantId - 8BF6BDA9E97D465DA9C0474CF4F62C4585FC49E1A63BA8CF6AF6C5B175B0BB3E Participant Details
- createdAtMillis - 1712835102244
- tweetId - 1778309538539532608
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Rak szyjki macicy nie jest nieszkodliwy, 5-letnia przeżywalność w Polsce wynosi tylko 48,3% Zespół Guillaina-Barrégo to bardzo rzadka choroba autoimmunologiczna powodująca paraliż, do tej pory nie znaleziono związku pomiędzy GBS a szczepionkami HPV https://onkologia.org.pl/pl/nowotwor-szyjki-macicy-czym-jest https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-11 11:31:42 UTC (1712835102244) |
2024-04-11 16:12:28 UTC (1712851948958) |
CURRENTLY_RATED_HELPFUL | 2024-04-12 11:24:43 UTC (1712921083732) |
CURRENTLY_RATED_HELPFUL | 2024-04-11 16:12:28 UTC (1712851948958) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-11 17:50:01 -0500 | Rating Details | |
| 2024-04-11 16:11:49 -0500 | Rating Details | |
| 2024-04-11 12:35:46 -0500 | Rating Details | |
| 2024-04-11 12:12:41 -0500 | Rating Details | |
| 2024-04-11 11:36:54 -0500 | Rating Details | |
| 2024-04-11 11:26:04 -0500 | Rating Details | |
| 2024-04-11 10:56:03 -0500 | Rating Details | |
| 2024-04-11 10:36:34 -0500 | Rating Details | |
| 2024-04-11 10:14:33 -0500 | Rating Details | |
| 2024-04-11 09:28:15 -0500 | Rating Details | |
| 2024-04-11 09:22:29 -0500 | Rating Details | |
| 2024-04-11 08:44:24 -0500 | Rating Details | |
| 2024-04-11 08:40:12 -0500 | Rating Details | |
| 2024-04-11 08:27:25 -0500 | Rating Details | |
| 2024-04-11 07:52:59 -0500 | Rating Details | |
| 2024-04-11 07:22:22 -0500 | Rating Details | |
| 2024-04-11 07:20:58 -0500 | Rating Details | |
| 2024-04-11 07:11:20 -0500 | Rating Details | |
| 2024-04-11 07:09:54 -0500 | Rating Details | |
| 2024-04-11 07:01:57 -0500 | Rating Details | |
| 2024-04-11 06:42:59 -0500 | Rating Details | |
| 2024-04-11 06:42:01 -0500 | Rating Details | |
| 2024-04-12 06:49:51 -0500 | Rating Details | |
| 2024-04-12 04:56:57 -0500 | Rating Details | |
| 2024-04-12 04:53:12 -0500 | Rating Details | |
| 2024-04-12 01:34:09 -0500 | Rating Details | |
| 2024-04-12 01:32:22 -0500 | Rating Details | |
| 2024-04-12 01:13:19 -0500 | Rating Details | |
| 2024-04-12 01:03:45 -0500 | Rating Details | |
| 2024-04-12 00:51:15 -0500 | Rating Details | |
| 2024-04-12 00:44:33 -0500 | Rating Details | |
| 2024-04-11 22:26:28 -0500 | Rating Details | |
| 2024-04-18 02:30:46 -0500 | Rating Details | |
| 2024-04-17 23:49:13 -0500 | Rating Details | |
| 2024-04-17 23:08:50 -0500 | Rating Details | |
| 2024-04-17 21:45:41 -0500 | Rating Details | |
| 2024-04-12 07:31:22 -0500 | Rating Details | |
| 2024-04-12 07:07:26 -0500 | Rating Details | |
| 2024-04-12 01:54:21 -0500 | Rating Details | |
| 2024-04-11 17:50:51 -0500 | Rating Details | |
| 2024-04-11 16:49:39 -0500 | Rating Details | |
| 2024-04-11 15:31:33 -0500 | Rating Details | |
| 2024-04-11 15:21:18 -0500 | Rating Details | |
| 2024-04-11 14:55:27 -0500 | Rating Details | |
| 2024-04-11 14:23:47 -0500 | Rating Details | |
| 2024-04-11 12:31:22 -0500 | Rating Details | |
| 2024-04-11 12:14:58 -0500 | Rating Details | |
| 2024-04-11 11:26:58 -0500 | Rating Details | |
| 2024-04-11 10:23:31 -0500 | Rating Details | |
| 2024-04-11 10:19:44 -0500 | Rating Details | |
| 2024-04-11 08:07:58 -0500 | Rating Details | |
| 2024-04-11 08:06:19 -0500 | Rating Details | |
| 2024-04-11 07:36:06 -0500 | Rating Details | |
| 2024-04-11 07:27:02 -0500 | Rating Details | |
| 2024-04-11 07:23:20 -0500 | Rating Details | |
| 2024-04-11 07:08:04 -0500 | Rating Details | |
| 2024-04-25 08:35:35 -0500 | Rating Details | |
| 2024-04-18 01:52:36 -0500 | Rating Details | |
| 2024-04-12 01:18:19 -0500 | Rating Details | |
| 2024-04-12 01:04:28 -0500 | Rating Details | |
| 2024-04-11 19:33:02 -0500 | Rating Details | |
| 2024-04-11 17:06:04 -0500 | Rating Details | |
| 2024-04-11 16:15:26 -0500 | Rating Details | |
| 2024-04-11 16:08:28 -0500 | Rating Details | |
| 2024-04-11 15:22:59 -0500 | Rating Details | |
| 2024-04-11 14:36:23 -0500 | Rating Details | |
| 2024-04-11 14:21:09 -0500 | Rating Details | |
| 2024-04-11 13:30:29 -0500 | Rating Details | |
| 2024-04-11 12:52:46 -0500 | Rating Details | |
| 2024-04-11 12:33:54 -0500 | Rating Details | |
| 2024-04-11 12:23:02 -0500 | Rating Details | |
| 2024-04-11 12:15:39 -0500 | Rating Details | |
| 2024-04-11 10:27:46 -0500 | Rating Details | |
| 2024-04-11 10:26:58 -0500 | Rating Details | |
| 2024-04-11 10:18:39 -0500 | Rating Details | |
| 2024-04-11 09:46:38 -0500 | Rating Details | |
| 2024-04-11 08:13:00 -0500 | Rating Details | |
| 2024-04-11 08:08:04 -0500 | Rating Details | |
| 2024-04-11 07:49:45 -0500 | Rating Details | |
| 2024-04-11 07:27:23 -0500 | Rating Details | |
| 2024-04-11 07:24:27 -0500 | Rating Details | |
| 2024-04-11 07:18:26 -0500 | Rating Details | |
| 2024-06-08 23:52:09 -0500 | Rating Details |